1. Neohesperidin Dihydrochalcone Ameliorates Experimental Colitis via Anti-Inflammatory, Antioxidative, and Antiapoptosis Effects.
- Author
-
Erdem I, Aktas S, and Ogut S
- Subjects
- Animals, Rats, Male, Humans, Tumor Necrosis Factor-alpha genetics, Tumor Necrosis Factor-alpha metabolism, Oxidative Stress drug effects, Interleukin-6 genetics, Interleukin-6 metabolism, Colitis drug therapy, Colitis chemically induced, Colitis metabolism, Interleukin-10 genetics, Interleukin-10 metabolism, Cyclooxygenase 2 metabolism, Cyclooxygenase 2 genetics, Colitis, Ulcerative drug therapy, Colitis, Ulcerative metabolism, Colitis, Ulcerative chemically induced, Malondialdehyde metabolism, Peroxidase metabolism, Interferon-gamma genetics, Interferon-gamma metabolism, Interferon-gamma immunology, Transforming Growth Factor beta1 metabolism, Transforming Growth Factor beta1 genetics, Rats, Wistar, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents chemistry, Anti-Inflammatory Agents administration & dosage, Antioxidants pharmacology, Apoptosis drug effects, Chalcones pharmacology, Chalcones administration & dosage, Hesperidin analogs & derivatives, Hesperidin pharmacology, Hesperidin administration & dosage, NF-kappa B genetics, NF-kappa B metabolism
- Abstract
Neohesperidin dihydrochalcone (NHDC) is a citrus-originated, seminatural sweetener. There is no investigation concerning the effect of NHDC on ulcerative colitis. The purpose of this study was to determine the therapeutic and protective effects of NHDC in Wistar Albino rats. NHDC was given for 7 days after or before colitis induction. The results showed that NHDC significantly reduced the interleukin-6 (IL-6), interleukin-10 (IL-10), transforming growth factor-β1 (TGF-β1), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) levels. Catalase levels did not show a significant difference between the groups. NHDC provided a remarkable decrease in the expression levels of cyclooxygenase-2 (COX-2), myeloperoxidase (MPO), malondialdehyde (MDA), 8-hydroxy-2'-deoxyguanosine (8-OHdG), and nuclear factor kappa B (NF-κB). Total antioxidant status (TAS) levels were significantly elevated in NHDC treatment groups, while total oxidant status (TOS) and oxidative stress index (OSI) levels were significantly decreased. NHDC provided remarkable improvement in histological symptoms such as epithelial erosion, edema, mucosal necrosis, inflammatory cell infiltration, and hemorrhage. Also, caspase-3 expression levels were statistically decreased in NHDC treatment groups. The results indicated that NHDC might be a protection or alternative treatment for ulcerative colitis.
- Published
- 2024
- Full Text
- View/download PDF